Guidelines

  1. Prostatic hyperplasia: AUA Guideline amendment 2020. J Urol 2020; 204: 799.

    1. View guidelines  

    2. 2020 amendment

  2. European Association of Urology (EAU) guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO). View guidelines

  3. Surgical and interventional management of benign prostatic obstruction: Guidelines from the Committee for Male Voiding Disorders of the French Urology Association.  Prog Urol 2021; 31(5): 249-265. View abstract

  4. NICE Medical Technologies Guidance (MTG58). UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia. 2021. View guidance

  5. NICE Interventional Procedure Guidance (IPG475).  Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia. 2014. View guidance

Meta-Analyses

  1. Tanneru K, Gautam S, Norez D, et al.  Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia.  Int Urol Nephrol. 2020; 52(6): 999-1008. View abstract

  2. Jing J, Wu Y, Du M, et al.  Urethral Lift as a Safe and Effective Procedure for Prostatic Hyplasia Population:  A Systematic Review and Meta-Analysis. Front Surg. 2020; 8(7): 598728. View article

  3. Perera M, Roberts MJ, Suhail ARD, Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol. 2015; 67; 704-713.  Addendum Eur Urol 2015; 68; E53-E54. View abstract

Randomized Controlled Studies

  1. L.I.F.T. Study

    1. Roehrborn CG, Barkin J, Gange SN, et al.  Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.  Can J Urol. 2017; 24(3): 8802-8813. View article

    2. Roehrbon CG. Prostatic  Urethral Lift A Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urol Clin N Am. 2016. 43:357-369. View abstract

    3. Roehrborn CG, Rukstalis DB, Barkin J, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol. 2015; 22(3): 7772-82. View article

    4. Roehrborn CG, Gange SN, Shore ND, et al. Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study. Urology Practice. 2015; 2(1):26-32. View article

    5. McVary KT, Gange SN, Shore ND. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med. 2014; 11(1):279-87. View abstract

    6. Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013; 190(6):2161-7. View abstract

  2. BPH6 Study

    1. Gratzke C, Barber N, Speakman MJ. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2017; 119(5):767-775. View article

    2. Sonksen J, Barber NJ, Speakman MJ, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015; 68(4):643-52. View article

Non-Randomized Comparative Studies

  1. Roehrborn CG, Rukstalis DB.  Prostatic Urethral Lift Versus Medical Therapy: Examining the Impact on Sexual Function in Men with Benign Prostatic Hyperplasia.  Eur Urol Focus.  2021; S2405-4569(20) 30315-1. View article

  2. Tutrone RF, Schiff W. Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection.  Can J Urol. 2020; 27(3): 10213-10219. View article

Single-Arm Studies

  1. MedLift Study

    1. Rukstalis D, Grier D, Stroup SP, et al.  Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2019; 22(3): 411-419. View article

  2. Crossover Study

    1. Rukstalis D, Rashid P, Bogache W, et al.  24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham. BJU Int. 2016; 118(Suppl 3): 14-22. View article

    2. Cantwell AL, Bogache WK, Richardson SF, et al. Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int. 2014; 113(4):615-22. View abstract

  3. LOCAL Study

    1. Shore N, Freedman S, Gange S, et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol. 2014; 21(1): 7094-101.* View article

  4. First-in-Human Study

    1. Chin PT, Bolton DM, Jack G, et al. Prostatic urethral lift: Two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2012; 79(1): 5-11.* View abstract

    2. Woo HH, Bolton DM, Laborde E. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med. 2012; 9(2):568-75. View abstract

    3. Woo HH, Chin PT, McNicholas TA. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011; 108(1): 82-8. View abstract

  5. Turkey Initial Study

    1. Bozkurt A, Karabakan M, Keskin E, Hirik E, Can Balci MB, Nuhoglu B. Prostatic Urethral Lift:   A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.  Urol Int. 2016; 96(2): 202-206. View abstract

    2. Akin Y, Bozkurt A, Keles MO, Gulmez H, Sahin M, Nuhoglu B. A Novel Minimally Invasive Treatment Option for Benign Prostat Hyperplasia:  Intraprostatic UroLift®, The First Case Series of Turkey with Short Term Follow-up. JAREM. 2013; 3: 74-8. View article

  6. France Initial Study

    1. Beurrier S, Peyromaure M, Belas O, Delongchamps NB. Are the UroLift® implants an alternative for the treatment of benign prostatic hyperplasia?  Short-term results and predictive factors of failure. Prog Urol. 2015; 25: 523-529. View abstract

    2. Delongchamps NB, Conquy S, Zerbib M, Peyromaure M. Intra-prostatic UroLift(®) implants for benign prostatic hyperplasia: preliminary results of the four first cases performed in France. Prog Urol. 2012; 22(10): 590-7. View abstract

  7. Spain Initial Study

    1. Garrido Abad P, Coloma Del Peso A, Sinues Ojas B, Fernandez Arjona M. Urolift®, a new minimally invasive treatment for patients with low urinary tract symptoms secondary to BPH. Preliminary results. Arch Esp Urol. 2013; 6696): 584-91. View abstract

  8. Large, Retrospective Real-World Studies

    1. Rabinowitz MJ, Alam R, Liu JL, et al.  Prostatic Urethral Lift in Patients With Obstructive Median Lobes: A Single Surgeon Experience at an Academic Center.  Urology. 2021; S0090-4295(21): 00088. View abstract

    2. Eure G, Gange S, Walter P, et al.  Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study.  J Endourol. 2019; 33(7): 576-584. View article

    3. Sievert KD, Schonthaler M, Berges R, et al. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.  World J Urol. 2019; 37(7):1353-1360. View article

  9. Chialastri P, Chialastri A, Mueller T.  Does Prostatic Urethral Lift Reduce Urinary Medications? Trends in Medical Treatment Before and After Prostatic Urethral Lift.  J Endourol. 2021; Jan 20. View abstract

  10. Kim JH, Lee KS, Kim TH et al.  Evaluation of Clinical Outcomes of Prostatic Urethral Lift for Benign Prostatic Hyperplasia: An Asian Population Study.  World J Mens Health. 2020; 38(3):338-344. View article

  11. Userovici M, Ochoa A, Anract J, Beurrier S, Peyromaure M, Delongchamps NB.  Prostatic urethral lift using Urolift® system for benign prostatic hyperplasia: 7 years experience.  Prog Urol. 2020; 30(3): 147-154. View article (click on View Open Manuscript)

  12. Al-Singary W, Patel R, Obi-Njoku O, Patel HRH. The UroLift ® System for lower urinary tract obstruction: patient selection for optimum clinical outcome. Minim Invasive Ther Allied Technol. 2020; 11: 1-6. View abstract

  13. Cayuelas Rubio C, Pallas Costa Y, Juan Escudero J, et al. Minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. Our initial experience with Urolift® under local anaesthesia and sedation.  Actas Urol Esp. 2019; 43(9): 488-494. View abstract

  14. Shah BB, Tayon K, Madiraju S, Carrion RE, Perito P.  Prostatic Urethral Lift:  Does Size Matter?  J Endourol. 2018; 32(7): 635-638. View abstract

  15. Bardoli AD, Taylor WSJ, Mahmalji W. Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature.  Aging Male. 2017; 20(3):192-197. View article

Technique Papers

  1. Ashley MS, Phillips J, Eure G. How I Do It: The prostatic urethral lift for obstrucgtive median lobes. Can J Urol. 2023;30(2): 11509-11515. View article

  2. Walsh LP.  State of the art: Advanced techniques for prostatic urethral lift for the relief of prostate obstruction under local anesthesia. Can J Urol.  2017; 24(3):8859-8864. View article

  3. McNicholas TA, Woo HH, Chin PT. Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol. 2013; 64(2): 292-9. View abstract

  4. Barkin J, Giddens J, Incze P. UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol. 2012; 19(2):6217-22. View article

Health Economics Papers

  1. Clarke JL. Optimizing Population Health and Economic Outcomes:  Innovative Treatment for BPH. Popul Health Manag. 2013; 16(Suppl 2): S1-S13. View article

*Denotes study included prostate volumes greater than FDA-cleared indications. The UroLift® System should not be used if the patient has a prostate volume > 100cc. Teleflex does not recommend or endorse use of the UroLift® System with prostate volumes >100 cc.